|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Induction and clonal expansion of tumor - specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells显示文摘 | KUROKAWA T OELKE M MACKENSEN A | 2001 | Int J Cancer2001，91，6： | 1 |
| 2 | The key principle for suc- cessful health systems integration 显示文摘 | Sether S Nelly D Oelke | 2009 | Heath care quarter- ly2009，13，： | 1 |
| 3 | Organizing Care across the Continuum: Primary Care, Specialty Services, Acute and Long - term Care 显示文摘 | Oelke N Cunning L Andrews K | 2009 | Healthcare Quarterly2009，13，10： | 1 |
| 4 | Age and bladder outlet obstruc- tion are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia 显示文摘 | Oelke M Baard J Wijkstra H | 2008 | Enr Urol2008，54，2： | 1 |
| 5 | Ten key principles for suc- cessful health systems integration显示文摘 | Surer E Oelke ND Adair CE | 2009 | Heahhcare Quarterly2009，13，10： | 1 |
| 6 | EAU guidelines on the treatment and follow-up of non-neuro- genic male lower urinary tract symptoms including be- nign prostatic obstruction显示文摘 | Oelke M Bachmann A Descazeaud A | 2013 | Eur Urol2013，64，1： | 1 |
| 7 | Generation and purification ofCD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer intumor immunotherapy显示文摘 | Oelke M Moehrle U Chen JL | 2000 | Clin Can Res2000，6，： | 1 |
| 8 | Monotherapy with tadala- fil or tamsulosin similarly improved lower urinary tract symp- toms suggestive of benign prostatic hyperplasia in an interna- tional, randomised, parallel, placebo-controlled clinical trial 显示文摘 | Oelke M Giuliano F Mirone V | 2012 | Eur Urol2012，61，5： | 1 |
| 9 | Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)显示文摘 | Gabuev A Oelke M | 2011 | Aktuelle Urologic2011，42，： | 1 |
| 10 | Interactions of monensin with dietary fat and carbohydrate components on ruminal fermentation and production responses by dairy cows显示文摘 | Mathew B Eastridge M L Oelke E R | 2011 | J Dairy Sci2011，94，： | 1 |
| 11 | Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina:relation to nitrie oxide synthase isoforrm and vasoactive intestinal polypepfide-containing nerves显示文摘 | Uckert S Oelke M Waldkirch E | 2005 | Urology2005，65，3： | 1 |
| 12 | Mitochondrial DNA and the origins of the domestic horse显示文摘 | Jansen T Forster P Levine M.a Oelke H. Hurles M. Renfrew C. Weber J. | | 0，，： | 1 |
| 13 | Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international,randomised,parallel,placebo -con- trolled clinical trial 显示文摘 | Oelke M Giuliano F Mirone V | 2012 | Eur Urol2012，61，5： | 1 |
| 14 | Age andbladder outlet obstruction are independently associatedwith detrusor overactivity in patients with benign prostatichyperplasia 显示文摘 | OELKE M BAARD J WIJKSTRA H | 2008 | Eur Urol2008，54，2： | 1 |
| 15 | EAU guidelines on the treatment and follow-up of non- neurogenic male lower urinary tract symptoms including benign prostatic obstruction显示文摘 | OELKE M BACHMANN A DESCAZEAUD A | 2013 | Eur Urol2013，64，1： | 1 |
| 16 | Nocturia: state of the art and critical analysis of current assessment and treatment strategies显示文摘 | Oelke M Adler E Marschall-Kehrel D | 2014 | World J Urol2014，32，5： | 1 |
| 17 | Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction显示文摘 | Thomas R. W. Herrmann T. Bach F. Imkamp A. Georgiou M. Burchardt M. Oelke A. J. Gross | 2010 | World Journal of Urology2010，，1： | 1 |
| 18 | Improving the health care of geriatric patients: management of urinary incon- tinence: a position paper 显示文摘 | Becher K Oelke M Grass-Kapanke B | 2013 | Gerontol Geriatr2013，46，5： | 1 |
| 19 | Functional characterization of CD8+ antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-Tetramer technology显示文摘 | Oelke M Kurokawa T Hentrich I | 2000 | Scand J Immunol2000，52，6： | 1 |
| 20 | EAUguidelines on the treatment and follow-up of non-neuro-genic male lower urinary tract symptoms including be-nign prostatic obstruction显示文摘 | Oelke M Bachmann A Descazeaud A | 2013 | Eur Urol2013，64，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员